eMERGE Phase IV Clinical Center at Mass General Brigham
eMERGE Phase IV Clinical Center at Mass General Brigham
批准号:
10834530
负责人:
ELIZABETH W KARLSON
金额:
$23.31万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
未结题
起止时间:
2015-09-01 至 2025-04-30
关键词:
AddressAdministrative SupplementAll of Us Research ProgramBaseline SurveysBiomedical ResearchBlack raceClinicalClinical TrialsCollectionCommunicationCommunication MethodsCommunication ResearchCommunication ToolsComprehensionConsentDataData CollectionDecentralizationDisparityEducationElectronic Health RecordElectronic MailElectronic Medical Records and Genomics NetworkEnsureEquityEthnic OriginFamilyGeneticGenomeGoalsHealthcareHispanicIndividualLanguageLatinoLearningLongitudinal StudiesMethodsModelingParticipantPhaseQuestionnairesRaceRecording of previous eventsReportingResearchRiskRisk FactorsSamplingSiteSourceSurveysTelephoneTextTimeTranslatingclinical centerclinical practicedisparity eliminationexperiencefollow-uphealth disparityhealth equityimprovednovelprogramsrecruitresponsesample collection
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract: To improve health equity in implementation of Genome Informed Risk Scores (GIRA)
in clinical practice, the eMERGE IV administrative supplement proposal leverages our expertise
from leading the All of Us Research Program retention campaign, and the MGB Decentralized
Clinical Trials Program, we are proposing to deploy novel communication methods and research
navigator workflows to enhance recruitment and retention in eMERGE. Specific aims: Aim 1:
Enhance equity in recruitment and return of GIRA results by employing novel communications
methods to diverse participants at baseline and at follow-up survey time points. We will develop
culturally sensitive new recruitment materials for Hispanic/Latino and Black participants, utilizing
plain language and graphics to explain study steps more clearly, explain that survey completion
is required to receive results and the importance of fully engaging at all points in this longitudinal
study. Our Spanish-speaking team will translate existing study materials to improve
comprehension by Hispanic/Latino participants. New and existing materials will be shared
throughout the eMERGE network to reduce survey data missingness and improve health equity.
Aim 2: Deploy a research navigator model with a diverse study team, to assign a navigator to
each participant, to guide and assist participants at each step in eMERGE from consent, survey
completion, sample collection, GIRA return, through collection of follow-up surveys. We will use
omni-channel communications based on participant choice (phone, text, email) and track
successful methods to inform the eMERGE network whether the navigator model with
personalized communication methods can be used at other sites. For participants who do not
complete surveys, we will perform chart reviews to collect key variables needed for GIRA to
increase the rate of equitable data collection and return of GIRA reports with minimal missing
data on demographic, clinical, and family history risk factors. Given the striking disparities in
data missingness the early phase of eMERGE IV by race and ethnicity, and the decision by the
network not to send samples for PRS analysis unless baseline survey data is provided by
participants, the study is at risk for introducing disparities in the return of results, thus biasing its
conclusions. Achieving health equity requires extra effort and focused methods to enhance
education, encourage full participation at each step of the program, provide assistance at an
individual level and gather data from available sources such as EHRs if we aim to eliminate
disparities in health and health care. Lessons learned in this administrative supplement will be
shared across the eMERGE network to enhance health equity of the entire study.
期刊论文(49)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
locStra: Fast analysis of regional/global stratification in whole-genome sequencing studies.
LOCSTRA:全基因组测序研究中区域/全球分层的快速分析。
DOI:
10.1002/gepi.22356
发表时间:
2021-03
期刊:
Genetic epidemiology
影响因子:
2.1
作者:
[Hahn G, Lutz SM, Hecker J, Prokopenko D, Cho MH, Silverman EK, Weiss ST, Lange C, NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium]
通讯作者:
NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium
DOI:
10.1016/j.wneu.2020.11.160
发表时间:
2021-03
期刊:
World neurosurgery
影响因子:
2
作者:
[Zhang J, Can A, Lai PMR, Mukundan S Jr, Castro VM, Dligach D, Finan S, Gainer VS, Shadick NA, Savova G, Murphy SN, Cai T, Weiss ST, Du R]
通讯作者:
Du R
The Mass General Brigham Biobank Portal: an i2b2-based data repository linking disparate and high-dimensional patient data to support multimodal analytics.
群众杨百卫生物银行门户网站:基于I2B2的数据存储库,将不同和高维患者数据连接起来,以支持多模式分析。
DOI:
10.1093/jamia/ocab264
发表时间:
2022-03-15
期刊:
Journal of the American Medical Informatics Association : JAMIA
影响因子:
--
作者:
[Castro VM, Gainer V, Wattanasin N, Benoit B, Cagan A, Ghosh B, Goryachev S, Metta R, Park H, Wang D, Mendis M, Rees M, Herrick C, Murphy SN]
通讯作者:
Murphy SN
Association between inflammation and systolic blood pressure in RA compared to patients without RA.
与非 RA 患者相比,RA 患者炎症与收缩压之间的关联。
DOI:
10.1186/s13075-018-1597-9
发表时间:
2018
期刊:
Arthritis research & therapy
影响因子:
4.9
作者:
[Yu,Zhi, Kim,SeoyoungC, Vanni,Kathleen, Huang,Jie, Desai,Rishi, Murphy,ShawnN, Solomon,DanielH, Liao,KatherineP]
通讯作者:
Liao,KatherineP
DOI:
10.1016/j.xgen.2023.100436
发表时间:
2023-12-13
期刊:
CELL GENOMICS
影响因子:
--
作者:
[Chen, Chia-Yen, Chen, Tzu-Ting, Anne, Yen-Chen, Yu, Mingru, Lin, Shu-Chi, Longchamps, Ryan J., Wang, Shi-Heng, Hsu, Yi-Hsian, Yang, Hwai-, I, Kuo, Po-Hsiu, Daly, Mark J., Chen, Wei J., Huang, Hailiang, Ge, Tian, Lin, Yen-Feng]
通讯作者:
Lin, Yen-Feng
共 22 条
eMERGE Phase IV Clinical Center at Partners HealthCare
-
批准号:10230561
-
项目类别:
-
资助金额:$88.31万
-
财政年份:2020
-
负责人:ELIZABETH W KARLSON
-
依托单位:
Joint Biology Consortium Resource-based Center
-
批准号:10281356
-
项目类别:
-
资助金额:$93.33万
-
财政年份:2016
-
负责人:ELIZABETH W KARLSON
-
依托单位:
Human Biosamples Core
-
批准号:10281358
-
项目类别:
-
资助金额:$35.97万
-
财政年份:2016
-
负责人:ELIZABETH W KARLSON
-
依托单位:
Joint Biology Consortium Resource-based Center
-
批准号:10454986
-
项目类别:
-
资助金额:$89.32万
-
财政年份:2016
-
负责人:ELIZABETH W KARLSON
-
依托单位:
A New England Enrollment Center for PMI Cohort Program
-
批准号:9453746
-
项目类别:
-
资助金额:$342.09万
-
财政年份:2016
-
负责人:ELIZABETH W KARLSON
-
依托单位:
A New England Enrollment Center for PMI Cohort Program
-
批准号:9355397
-
项目类别:
-
资助金额:$121.12万
-
财政年份:2016
-
负责人:ELIZABETH W KARLSON
-
依托单位:
Human Biosamples Core
-
批准号:10684883
-
项目类别:
-
资助金额:$33.99万
-
财政年份:2016
-
负责人:ELIZABETH W KARLSON
-
依托单位:
Human Biosamples Core
-
批准号:10454988
-
项目类别:
-
资助金额:$33.99万
-
财政年份:2016
-
负责人:ELIZABETH W KARLSON
-
依托单位:
EMERGE PHASE III CLINICAL CENTER AT PARTNERS HEALTHCARE
-
批准号:9493516
-
项目类别:
-
资助金额:$95.32万
-
财政年份:2015
-
负责人:ELIZABETH W KARLSON
-
依托单位:
eMERGE Phase IV Clinical Center at Mass General Brigham
-
批准号:10625354
-
项目类别:
-
资助金额:$116.7万
-
财政年份:2015
-
负责人:ELIZABETH W KARLSON
-
依托单位:
EMERGE PHASE III CLINICAL CENTER AT PARTNERS HEALTHCARE
-
批准号:9284512
-
项目类别:
-
资助金额:$91.62万
-
财政年份:2015
-
负责人:ELIZABETH W KARLSON
-
依托单位:
EMERGE PHASE III CLINICAL CENTER AT PARTNERS HEALTHCARE
-
批准号:8968123
-
项目类别:
-
资助金额:$97.24万
-
财政年份:2015
-
负责人:ELIZABETH W KARLSON
-
依托单位:
EMERGE PHASE III CLINICAL CENTER AT PARTNERS HEALTHCARE
-
批准号:9134764
-
项目类别:
-
资助金额:$95.32万
-
财政年份:2015
-
负责人:ELIZABETH W KARLSON
-
依托单位:
Finding Genomic Profiles of COVID-19 Phenotypes from the EHR
-
批准号:10166411
-
项目类别:
-
资助金额:$40.19万
-
财政年份:2015
-
负责人:ELIZABETH W KARLSON
-
依托单位:
EMERGE PHASE III CLINICAL CENTER AT PARTNERS HEALTHCARE
-
批准号:9477855
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2015
-
负责人:ELIZABETH W KARLSON
-
依托单位:
eMERGE Phase IV Clinical Center at Mass General Brigham
-
批准号:10207715
-
项目类别:
-
资助金额:$141.56万
-
财政年份:2015
-
负责人:ELIZABETH W KARLSON
-
依托单位:
Communication of biomarker, genetic, lifestyle risk factor profiles for RA
-
批准号:8293776
-
项目类别:
-
资助金额:$39.75万
-
财政年份:2012
-
负责人:ELIZABETH W KARLSON
-
依托单位:
ACR Clinical Research Conference
-
批准号:8006327
-
项目类别:
-
资助金额:$3.0万
-
财政年份:2010
-
负责人:ELIZABETH W KARLSON
-
依托单位:
ACR Clinical Research Conference
-
批准号:8207806
-
项目类别:
-
资助金额:$3.0万
-
财政年份:2010
-
负责人:ELIZABETH W KARLSON
-
依托单位:
ACR Clinical Research Conference
-
批准号:8315729
-
项目类别:
-
资助金额:$3.0万
-
财政年份:2010
-
负责人:ELIZABETH W KARLSON
-
依托单位:
海外基金